The interplay between NF-κB, inflammation, and cancer was first highlighted in hepatitis-related liver cancer and colitis-related colon cancer, where NF-κB acts as a key mediator linking chronic inflammation to tumorigenesis [143]. Here, NFKB1 is linked to malignant colon neoplasm.